Agilent Technologies, Inc. $A Stock Sold by Fenimore Asset Management Inc

Fenimore Asset Management Inc lessened its position in Agilent Technologies, Inc. (NYSE:A) by 0.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 558,284 shares of the medical research company’s stock after selling 3,091 shares during the period. Agilent Technologies comprises 2.1% of Fenimore Asset Management Inc’s portfolio, making the stock its 18th largest holding. Fenimore Asset Management Inc owned about 0.20% of Agilent Technologies worth $96,198,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Everhart Financial Group Inc. increased its holdings in shares of Agilent Technologies by 13.2% in the 3rd quarter. Everhart Financial Group Inc. now owns 4,194 shares of the medical research company’s stock worth $723,000 after purchasing an additional 488 shares in the last quarter. Valeo Financial Advisors LLC bought a new position in shares of Agilent Technologies during the third quarter valued at $264,000. Plan A Wealth LLC boosted its position in shares of Agilent Technologies by 1.9% during the third quarter. Plan A Wealth LLC now owns 3,567 shares of the medical research company’s stock valued at $615,000 after buying an additional 68 shares during the last quarter. Elevation Wealth Partners LLC boosted its position in shares of Agilent Technologies by 2.6% during the third quarter. Elevation Wealth Partners LLC now owns 4,655 shares of the medical research company’s stock valued at $802,000 after buying an additional 119 shares during the last quarter. Finally, S.E.E.D. Planning Group LLC increased its holdings in Agilent Technologies by 31.1% in the 3rd quarter. S.E.E.D. Planning Group LLC now owns 6,701 shares of the medical research company’s stock worth $1,155,000 after buying an additional 1,591 shares in the last quarter.

Agilent Technologies Stock Performance

Shares of NYSE:A traded down $1.01 during trading on Thursday, hitting $168.07. The company’s stock had a trading volume of 2,718,111 shares, compared to its average volume of 2,278,284. The company has a 50-day moving average of $154.62 and a 200-day moving average of $134.78. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $177.05. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. The firm has a market cap of $47.39 billion, a price-to-earnings ratio of 33.09, a P/E/G ratio of 2.58 and a beta of 1.21.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The company had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.84 billion. During the same period in the previous year, the business posted $1.37 earnings per share. The firm’s quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 6.2 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th will be issued a $0.2550 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, October 6th. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.08%.

Analyst Ratings Changes

A number of equities analysts have weighed in on A shares. Stifel Nicolaus boosted their target price on Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a research report on Thursday, August 27th. Piper Sandler assumed coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target on the stock. Morgan Stanley lifted their price target on shares of Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Wall Street Zen cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Saturday, October 3rd. Finally, JPMorgan Chase & Co. increased their price objective on shares of Agilent Technologies from $180.00 to $190.00 and gave the company an “overweight” rating in a research report on Thursday, August 27th. Fourteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, Agilent Technologies has a consensus rating of “Moderate Buy” and an average price target of $171.82.

Insider Buying and Selling

In related news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the transaction, the director directly owned 4,924 shares in the company, valued at approximately $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Agilent Technologies Company Profile

Agilent Technologies, Inc is an analytical measurement and laboratory technology company serving the life sciences, diagnostics, pharmaceutical, chemical, environmental, food, energy and academic research markets. Its solutions help laboratories analyze the composition, quality and performance of materials, biological samples and other substances.

The company’s products and services include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy equipment, laboratory automation tools, software, consumables and supplies.